MarketInOut Stock Screener Log In | Sign Up
 

ALK-Abelló A/S

CPH • Healthcare • Biotechnology • Quote as of 09/08/2026 16:59
ALK-Abelló A/S stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeCPH
Market Capitalization46,001 mln
Float132 mln
Earnings Date11/17/2026

EPS

6.10
Stretched

P / E

33.54
Overvalued

1-Year Forecast

294
Exceptional upside

Relative Strength

15 / 100
Significantly lagging

Debt / Equity

0.06
Debt-free

ROE

21.21
Strong

Business Description

Founded in 1923 and based in Hørsholm, Denmark, ALK-Abelló is a medical company focused on helping people manage and treat allergies. Its core products include a range of immunotherapy treatments ? delivered as tablets, drops, or injections ? that target common allergies such as grass and tree pollen, house dust mites, ragweed, and peanuts, along with emergency medicines for severe allergic reactions like anaphylaxis. The company also offers diagnostic tools, a digital platform to help patients track and manage their condition, and is developing new biological treatments for food allergies. ALK-Abelló operates across Europe, North America, Asia, and other markets, working with partners such as Torii Pharmaceutical and Dr. Reddy's Laboratories to bring its products to patients worldwide.

Key Fundamentals

EPS6.10
P/E33.54
ROE21.21
RPS30.73
ROA12.74
EBITDA, mln2,095
EV / EBITDA21.49
Revenue, mln6,829
EV / Revenue6.59

Financial Strength

1-Year Target Price294

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.94% 7 / 100   
1 Month -7.25% 6 / 100   
2 Months -21.97% 1 / 100   
6 Months -8.37% 9 / 100   
1 Year 1.45% 27 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us